Acute recurrent polyhydramnios: a combination of amniocenteses and NSAID may be curative rather than palliative

Fetal Diagn Ther. 2007;22(3):186-9. doi: 10.1159/000098714. Epub 2007 Jan 16.

Abstract

Acute recurrent polyhydramnios is a rare occurrence characterized by a poor fetal outcome. This is a case report describing a 34-year-old woman presenting with acute recurrent polyhydramnios. Treatment with non-steroidal anti-inflammatory drugs (NSAID) and therapeutic amniocenteses was initiated immediately and resulted in a decreased amniotic fluid production from 30 weeks' gestation. Even after the discontinuation of NSAID treatment, the amniotic fluid production normalized, and the woman delivered a healthy boy at 39 weeks 2 days' gestation. Amniotic prolactin was measured at three occasions using an enzyme-linked immunosorbent assay. As in normal pregnancies, amniotic prolactin levels decreased by 80% from highest to lowest value in this case of resolving acute recurrent polyhydramnios.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Amniocentesis / methods*
  • Amniotic Fluid / metabolism
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Combined Modality Therapy
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Polyhydramnios / drug therapy*
  • Polyhydramnios / etiology
  • Polyhydramnios / metabolism
  • Polyhydramnios / therapy*
  • Pregnancy
  • Prolactin / metabolism
  • Receptors, Prolactin / metabolism
  • Recurrence

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Receptors, Prolactin
  • Prolactin